Chahra Khaoua Epouse Louafi
Presidente presso INSERM Transfert Initiative SAS
Provenienza dei contatti di primo grado di Chahra Khaoua Epouse Louafi
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development.
81
| Subsidiary | Investment Managers | 81 |
Extinct | Pharmaceuticals: Major | 16 | |
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France.
9
| Holding Company | Biotechnology | 9 |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.
9
| Holding Company | Miscellaneous Commercial Services | 9 |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland.
8
| Subsidiary | Biotechnology | 8 |
In Situ Training SAS
In Situ Training SAS Miscellaneous Commercial ServicesCommercial Services In Situ Training SAS provides medical training services. It specializes in e-medicine, Medical Training, In Situ Training, Digital Health, e-health and Training inside the OR. The company was founded by Patxi Ospital and Julien Delpech in 2015 and is headquartered in Pessac, France.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Incepto Medical SAS
Incepto Medical SAS Packaged SoftwareTechnology Services Incepto Medical SAS develops and distributes artificial intelligent (AI) based medical imaging applications. It offers solutions for computed tomography (CT) scans, chest x-ray, and detections for conditions such as fracture and bowel occlusion. The company was founded by Antoine Jomier, Florence Moreau, Vincent Barrau, Jean Michel Malbrancq, and Gaspard d’Assignies and is headquartered in Paris, France.
4
| Holding Company | Packaged Software | 4 |
Brainever SAS
Brainever SAS Pharmaceuticals: MajorHealth Technology Brainever SAS manufactures pharmaceutical products. It develops medicines for nervous system diseases. The company was founded on March 31, 2015 and is headquartered in Paris, France.
2
| Holding Company | Pharmaceuticals: Major | 2 |
CDC Enterprises, Inc.
CDC Enterprises, Inc. Electrical ProductsProducer Manufacturing CDC Enterprises, Inc. designs, manufactures, and distributes patented HDPE ductwork products. It offers airtight, mildew, corrosion resistant, and thermal constructed ductwork products. The firm specializes in electrical instrumentation, controls and systems integration, for public works, utilities, private industry, and government organizations. It provides a wide range of services including pump efficiency monitoring, system diagnostics and troubleshooting, GPS mapping, robotic controls, panel design, and fabrication. The company was founded by Jon W. Jungers in April 2001 and is headquartered in Ringwood, IL.
1
| Private Company | Electrical Products | 1 |
Doctoconsult SAS
Doctoconsult SAS Internet Software/ServicesTechnology Services Doctoconsult SAS operates an online portal, which provides telemedecine services. It specializes in mental health. The company was founded by Grevent Fanny Jacq in 2016 and is headquartered in Fresnes, France.
1
| Subsidiary | Internet Software/Services | 1 |
INSERM Transfert Initiative SAS
INSERM Transfert Initiative SAS Investment ManagersFinance INSERM Transfert Initiative SAS is a venture capital fund that invests in companies located in France. It targets startups from the life sciences and biotechnology sectors, developing new medical practices with a strong intellectual property. It invests between €1 million and €3 million per company during mostly at pre-seed, seed and early-stages.
1
| Venture Capital Fund | Investment Managers | 1 |
Therachon SAS
Therachon SAS BiotechnologyHealth Technology TherAchon SAS provides biotechnology services. It specializes in research and development for achondroplasia and its associated complications. The company was founded by Elvire Gouze in 2014 and is headquartered in Biot, France.
1
| Subsidiary | Biotechnology | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Chahra Khaoua Epouse Louafi tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ORANGE | Wireless Telecommunications | Director/Board Member Director/Board Member Corporate Officer/Principal | |
CAPGEMINI SE | Information Technology Services | Director of Finance/CFO Corporate Officer/Principal | |
EUTELSAT COMMUNICATIONS | Major Telecommunications | Director/Board Member Director/Board Member Director/Board Member | |
POXEL | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
FT1CI
FT1CI Other Metals/MineralsNon-Energy Minerals FT1CI provides services to nuclear power plants such as uranium mining and fuel production, maintenance and engineering services, recycling and processing of nuclear waste, and manufactures nuclear power generation, transmission and distribution equipment. It is headquartered in Paris, France. | Other Metals/Minerals | Chief Executive Officer Director/Board Member | |
NEXANS | Electrical Products | Director/Board Member Director/Board Member | |
MERSEN | Electrical Products | Director/Board Member Director/Board Member Director/Board Member | |
Bpifrance SA
Bpifrance SA Finance/Rental/LeasingFinance Bpifrance SA provides aids and financial support to small and medium companies. Its solutions include loans, insurance, warranties, and equity investments. The creation of the BPI was formalized by Law no. 2012-1559 on 31 December 2012, amending Ordinance no. 2005-722 of June 29, 2005, relating to the creation of the public institution OSEO, which became EPIC BPI-Groupe then EPIC Bpifrance, and the public limited company OSEO (now Bpifrance). The company was founded in 1923 and headquartered in Maisons-Alfort, France. | Finance/Rental/Leasing | Chief Executive Officer Director/Board Member Director/Board Member | |
INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
EM Lyon Business School | College/University | Graduate Degree Undergraduate Degree | |
Sciences Po | College/University | Undergraduate Degree Graduate Degree | |
SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Ecole Polytechnique | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
Ecole Nationale d'Administration | College/University | Undergraduate Degree Undergraduate Degree | |
EOS IMAGING | Medical Specialties | Director/Board Member Director/Board Member | |
TXCELL | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
CDC Croissance SA
CDC Croissance SA Investment ManagersFinance CDC Croissance SA is an asset management firm headquartered in Paris, France. It was founded in 2001 as CDC Entreprises Valeurs Moyennes SAS. The firm is a subsidiary of BPIFrance Investissement, which in turn is a subsidiary of government-owned Caisse d'Amortissement de la Dette Sociale. CDC Croissance manages assets of individual and institutional clients. | Investment Managers | Chief Investment Officer Corporate Officer/Principal Chief Executive Officer | |
VOLUNTIS S.A. | Packaged Software | Director/Board Member Director/Board Member Director/Board Member | |
ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Bpifrance Participations SA /PRIVATE EQUITY/
Bpifrance Participations SA /PRIVATE EQUITY/ Investment ManagersFinance Bpifrance Participations SA/ PRIVATE EQUITY/ (BPIfrance Participations PE) is the private equity division of Bpifrance Participations SA subsidiary of State-owned Caisse des Dépots & Consignations headquartered in France. Formerly known as Fonds Stratégique d'Investissement SA (Private Equity), the firm was established in 2008 by the Government of France in an aim to strengthen distressed companies of strategic importance for the French economy. Based in Paris, BPIfrance Participations specializes in fund of funds and direct investments in French intermediate-sized companies. | Investment Managers | Director/Board Member Private Equity Investor Private Equity Analyst Private Equity Analyst Private Equity Analyst | |
SENSORION | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Amundi Private Equity Funds SA
Amundi Private Equity Funds SA Investment ManagersFinance Amundi Private Equity Funds SA (Amundi PEF) is the private equity subsidiary of Amundi SA, itself a subsidiary of Crédit Agricole SA (XP: ACA) in France. Formerly known as CAAM-CI, founded in 1999 as CPR Private Equity, Amundi PEF was formed in 2009 by combining the Crédit Agricole and Société Générale asset management operations. The firm is headquartered in Paris and has additional offices in Bucharest, Cairo, Casablanca, Tunis and Warsaw. They invest in companies at all stages of development, providing institutional and individual investors with a wide spectrum of investment opportunities. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Consolidation & Développement Gestion SAS
Consolidation & Développement Gestion SAS Investment ManagersFinance Consolidation & Développement Gestion SAS (Consolidation Dev Gestion) is a private equity firm headquartered in paris, France. It was founded in 2009 and is a subsidary of BPIFrance Investissement SAS. | Investment Managers | Chairman Private Equity Analyst | |
ADVICENNE | Pharmaceuticals: Generic | Chairman Director/Board Member Director/Board Member | |
École des Hautes Études Commerciales du Nord | College/University | Undergraduate Degree Graduate Degree | |
PIXIUM VISION | Medical Specialties | Founder Director/Board Member Director/Board Member | |
GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Bpifrance Participations SA | Financial Conglomerates | Chief Executive Officer Chief Investment Officer | |
Banque Publique d'Investissement
Banque Publique d'Investissement Finance/Rental/LeasingFinance Banque Publique Dinvestissement (Bpifrance) is the French Government's public investment institution which was created in 2013 to 'serve the future' by providing financing solutions tailored to each stage of a company's life. Located in Maisons-Alfort, Bpifrance aims to invest EUR 12 billion in French companies by 2017. Their three main tasks are: to help overcome market failures that hamper the financing of enterprises, especially SMEs; to invest in the development of strategic sectors such as digital conversion, environmental and energy, and the social and solidarity economy; and to act as a lever to develop territories in connection with regions in France. Bpifrance includes OSEO, CDC Entreprises, FSI and FSI Regions. OSEO is a public institution whose mission is to support innovation and growth of SMEs. CDC Entreprises is a management company that invests directly or indirectly in SMEs and ETIs at all stages of their development. FSI is an investment fund established by the French government in 2008 to help French companies seeking stable investors to finance their development projects and FSI Régions is a management company which provides regional investment capital. In 2013, OSEO will become Bpifrance Financement and Bpifrance Investissement will regroup CDC Entreprises, FSI and FSI régions. CDC Entreprises, FSI and FSI Régions will merge to become Bpifrance Investment. | Finance/Rental/Leasing | Chief Executive Officer Corporate Officer/Principal | |
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chairman | |
GamaMabs Pharma SA
GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
ABIVAX | Pharmaceuticals: Other | Director/Board Member Investor Relations Contact | |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Dynacure SA
Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
UroMems SAS
UroMems SAS Medical SpecialtiesHealth Technology UroMems SASdesigns and develops implantable medical devices. Its product is an active implantable medical device which compensates for sphincter insufficiency with the help of a MyoElectroMechanical System. The company was founded by Hamid Lamraoui in 2011 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Director/Board Member | |
ACTICOR BIOTECH SAS | Biotechnology | Director/Board Member Director/Board Member | |
DNA Script SAS
DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
PASSAGE BIO, INC. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
Noema Pharma AG
Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Founder | |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
NH THERAGUIX SAS | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
Francia | 45 |
Svizzera | 4 |
Stati Uniti | 2 |
Germania | 2 |
Settori
Health Technology | 24 |
Finance | 10 |
Consumer Services | 8 |
Communications | 3 |
Technology Services | 3 |
Posizioni
Director/Board Member | 557 |
Corporate Officer/Principal | 81 |
Private Equity Investor | 75 |
Chairman | 74 |
Independent Dir/Board Member | 70 |
Contatti più connessi
Insiders | |
---|---|
Anne-Sophie Herelle | 65 |
Nicolas Dufourcq | 53 |
Vanessa Giraud | 41 |
Stephen P. Squinto | 40 |
Thomas Woiwode | 39 |
Jérôme Gallot | 33 |
Bernard Gilly | 32 |
Catherine Moukheibir | 29 |
François Thomas | 25 |
Philippe Boucheron | 24 |
Johannes G. C. P. Schikan | 22 |
Laurent Arthaud | 21 |
Maïlys Ferrère | 21 |
Marie-Laure Garrigues | 19 |
Sandipkumar S. Kapadia | 19 |
- Borsa valori
- Insiders
- Chahra Khaoua Epouse Louafi
- Connessioni Società